Ameliorative Effect of Empagliflozin and Linagliptin on Cisplatin-Induced Nephrotoxicity and Cardiotoxicity by Reducing Oxidative Stress
Malak Salah Alharbi, Maha Abdulrahman Aldubayan · 2025
Read Ameliorative Effect of Empagliflozin and Linagliptin on Cisplatin-Induced Nephrotoxicity and Cardiotoxicity by Reducing Oxidative Stress by Malak Salah Alharbi, Maha Abdulrahman Aldubayan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12744234.txt.
Description
Malak Salah Alharbi and Maha Abdulrahman Aldubayan test whether two diabetes drugs can protect the kidneys and heart from damage caused by cisplatin, a chemotherapy drug. Their study came out in 2025 and used rats that did not have diabetes.
Animals received the diabetes drugs, alone or together, around doses of cisplatin. Cisplatin alone raised kidney, heart, and oxidative stress markers, meaning signs of damage from reactive oxygen, and lowered protective enzyme activity. Either drug alone reduced several damage markers. The combination lowered a key fat-damage marker in both organs and restored protective enzymes best. One drug showed weaker antioxidant effects in the heart than in the kidney. The authors suggest the pair may limit cisplatin toxicity.
Catalog record
| CREATOR | Malak Salah Alharbi, Maha Abdulrahman Aldubayan |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |